QA: Transcode Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001829635_2024_Transcode_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001829635, Transcode Therapeutics Inc

  xvar xval
0 AssetsCurrent 4,455,444
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 120,707
3 remainder_Assets 593,550
4 LiabilitiesCurrent 3,490,596
5 LiabilitiesNoncurrent 38,291
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,154,986
9 ResearchAndDevelopmentExpense 12,263,530
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 872,421
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,169,701
1 Liabilities 3,528,887
2 Expenses 19,418,516
3 Revenues 0
4 StockholdersEquity 1,640,814
5 NetIncome -18,546,095
6 ComprehensiveNetIncome -18,546,095
7 BaseVar 14,494,762
8 EconomicCapitalRatiobeforeLimitedLiability -3.44
9 EconomicCapitalRatio 0.547

Edgar->Model Mapping

Feature Distribution

Change over Time